Air bubbles prompt Bayer action over potential analyser problem:
This article was originally published in Clinica
Executive Summary
Bayer has issued a medical device alert to the five French hospitals that may be affected by potential problems with its 3.1 version of software for the Rapidpoint 405 analyser, which carries out blood gas analysis. The alert, sent out in conjunction with the French healthcare products safety agency, AFSSAPS, urgently advises operators to immediately install a new version of software that it is making available, so that an unlikely, but potential problem does not occur. The former software was not capable of detecting air bubbles in the sample circuit, which could lead to an overly low blood gas analysis reading.